Parabilis Medicines

Executive Summary

Parabilis Medicines is a private, early-stage biologics company founded in 2020 and headquartered in San Diego. The company is focused on developing transformative therapies with the potential for life-changing impact, prioritizing meaningful innovation over incremental improvements. While specific pipeline details and financials are not publicly disclosed, the company's mission and positioning suggest a commitment to novel biologic modalities. Given its private status and lack of reported clinical-stage assets, Parabilis is likely in preclinical or discovery stages, with a long development timeline ahead.

Upcoming Catalysts (preview)

• 2026Series A/B financing round30% success
• TBDLead program IND filing10% success